Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (74)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Effects of COVID-19-Associated Pulmonary Aspergillosis (CAPA) on the prognosis of severe COVID-19: Clinical characteristics and risk factors in a second-level hospital from Southern Spain

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain

    Health Science Reports, Vol. 7, Núm. 3

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia

    International journal of molecular sciences, Vol. 24, Núm. 3

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study

    Antibiotics, Vol. 12, Núm. 3

  5. Molecular characterization of patients with chronic hepatitis C virus infection in Jordan: implications on response to direct-acting antiviral therapy

    International Journal of Infectious Diseases, Vol. 135, pp. 63-66

  6. Mpox Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May–September 2022 International Outbreak

    AIDS Research and Human Retroviruses, Vol. 39, Núm. 11, pp. 604-609

2022

  1. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant

    Transboundary and Emerging Diseases, Vol. 69, Núm. 5, pp. 2649-2655

2021

  1. Comparison between Aptima® assays (Hologic) and the CoBAS® 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 6, pp. 1337-1342

  2. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  3. Highly accurate whole-genome imputation of SARS-CoV-2 from partial or low-quality sequences

    GigaScience, Vol. 10, Núm. 12

  4. Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019

    Sexually Transmitted Infections, Vol. 97, Núm. 1, pp. 8-10

  5. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  6. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  7. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. A multi-omics approach reveals new signatures in obese allergic asthmatic children

    Biomedicines, Vol. 8, Núm. 9